Drug Development Global Program

Categories: Neglected Tropical Diseases

Support for drug registration to fight visceral leishmaniasis in Bangladesh

In partnership with others, PATH developed paromomycin intramuscular injection (PMIM) as a new, safe, effective, and affordable treatment option for VL and worked with leading clinical researchers and an Indian pharmaceutical company to manufacture the drug and register it with India’s national drug regulatory agency in 2006. Continue reading »